A Review on Shikonin and its Derivatives as Potent Anticancer Agents Targeted against Topoisomerases

拓扑异构酶 喜树碱 化学 药理学 细胞毒性 拓扑异构酶抑制剂 天然产物 抗癌药 药品 生物化学 生物 体外
作者
Olagoke Zacchaeus Olatunde,Jianping Yong,Can‐Zhong Lu,Yanlin Ming
出处
期刊:Current Medicinal Chemistry [Bentham Science Publishers]
卷期号:31 (8): 920-937 被引量:6
标识
DOI:10.2174/0929867330666230208094828
摘要

Abstract: The topoisomerases (TOPO) play indispensable roles in DNA metabolism, by regulating the topological state of DNA. Topoisomerase I and II are the well-established drug-targets for the development of anticancer agents and antibiotics. These drugs-targeting enzymes have been used to establish the relationship between drug-stimulated DNA cleavable complex formation and cytotoxicity. Some anticancer drugs (such as camptothecin, anthracyclines, mitoxantrone) are also widely used as Topo I and Topo II inhibitors, but the poor water solubility, myeloma suppression, dose-dependent cardiotoxicity, and multidrug resistance (MDR) limited their prolong use as therapeutics. Also, most of these agents displayed selective inhibition only against Topo I or II. In recent years, researchers focus on the design and synthesis of the dual Topo I and II inhibitors, or the discovery of the dual Topo I and II inhibitors from natural products. Shikonin (a natural compound with anthraquinone skeleton, isolated from the roots of Lithospermum erythrorhizon) has drawn much attention due to its wide spectrum of anticancer activities, especially due to its dual Topo inhibitive performance, and without the adverse side effects, and different kinds of shikonin derivatives have been synthesized as TOPO inhibitors for the development of anticancer agents. In this review, the progress of the shikonin and its derivatives together with their anticancer activities, anticancer mechanism, and their structure-activity relationship (SAR) was comprehensively summarized by searching the CNKI, PubMed, Web of Science, Scopus, and Google Scholar databases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
胖胖橘完成签到 ,获得积分10
1秒前
四叶草完成签到 ,获得积分10
6秒前
6秒前
梦希陌完成签到,获得积分10
9秒前
船夫完成签到,获得积分10
22秒前
鲲鹏完成签到 ,获得积分10
27秒前
nine2652完成签到 ,获得积分10
32秒前
小谭完成签到 ,获得积分10
32秒前
小羊咩完成签到 ,获得积分10
36秒前
我爱康康文献完成签到 ,获得积分10
36秒前
penguin完成签到,获得积分10
40秒前
btcat完成签到,获得积分10
55秒前
ChatGPT发布了新的文献求助10
56秒前
guoxihan完成签到,获得积分10
56秒前
淞淞于我完成签到 ,获得积分10
59秒前
机智幻香完成签到 ,获得积分10
1分钟前
糖宝完成签到 ,获得积分10
1分钟前
兔兔完成签到 ,获得积分10
1分钟前
俊逸吐司完成签到 ,获得积分10
1分钟前
AUGKING27完成签到 ,获得积分10
1分钟前
shuangfeng1853完成签到 ,获得积分10
1分钟前
fatcat完成签到,获得积分10
1分钟前
飞龙在天完成签到,获得积分0
1分钟前
湖以完成签到 ,获得积分10
1分钟前
菠萝蜜完成签到,获得积分10
1分钟前
千千完成签到,获得积分10
1分钟前
过时的砖头完成签到 ,获得积分20
1分钟前
wanjingwan完成签到 ,获得积分10
1分钟前
从心随缘完成签到 ,获得积分10
1分钟前
dodo应助詩翰采纳,获得200
2分钟前
eternal_dreams完成签到 ,获得积分10
2分钟前
海阔天空完成签到 ,获得积分10
2分钟前
执着夏岚完成签到 ,获得积分10
2分钟前
小蘑菇应助科研通管家采纳,获得10
2分钟前
华仔应助科研通管家采纳,获得10
2分钟前
风中的向卉完成签到 ,获得积分10
2分钟前
多边形完成签到 ,获得积分10
2分钟前
Thien发布了新的文献求助10
2分钟前
纯真的梦竹完成签到,获得积分10
2分钟前
特别圆的正方形完成签到 ,获得积分10
2分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Residual Stress Measurement by X-Ray Diffraction, 2003 Edition HS-784/2003 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3949990
求助须知:如何正确求助?哪些是违规求助? 3495297
关于积分的说明 11076106
捐赠科研通 3225837
什么是DOI,文献DOI怎么找? 1783309
邀请新用户注册赠送积分活动 867589
科研通“疑难数据库(出版商)”最低求助积分说明 800839